StonvexLoading…
StonvexCore line items from SPXC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.27B | $1.98B | $1.74B | $1.46B |
Operating Income | $350.40M | $308.30M | $221.90M | $51.00M |
Net Income | $244.00M | $200.50M | $89.90M | $200.00K |
EPS (Diluted) | $5.03 | $4.26 | $1.93 | $0.00 |
Total Assets | $3.60B | $2.71B | $2.44B | $1.93B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $364.00M | $156.90M | $99.40M | $147.80M |
Free Cash Flow OCF − CapEx | $241.20M | $247.90M | $184.60M | $-152.70M |
Shares Outstanding | 49.87M | 46.37M | 45.67M | 45.29M |